Pharmacovigilance and Real-World Data: Detecting Long-Term Drug Effects

Pharmacovigilance is the science and activities related to the detection, assessment, understanding, and prevention of adverse drug reactions (ADRs) and drug-related problems. As the use of medications continues to grow globally, the need for robust systems to monitor the long-term effects of drugs becomes increasingly important. Traditional clinical trials often have limited duration and sample sizes, which can result in underreporting or delayed recognition of long-term drug effects. This review explores the role of pharmacovigilance and real-world data (RWD) in identifying and assessing the long-term safety of drugs post-market. We discuss the methods for collecting RWD, including electronic health records (EHR), insurance claims data, patient registries, and social media monitoring, and how these sources can be integrated into pharmacovigilance frameworks. By using RWD, researchers can identify rare adverse events, understand the real-world effectiveness of treatments, and track long-term safety outcomes in diverse populations. Additionally, we address the challenges associated with RWD, including data quality, heterogeneity, and privacy concerns. The review highlights the importance of advanced data analytics and artificial intelligence in enhancing pharmacovigilance efforts. Finally, we examine case studies where RWD has significantly contributed to the detection of long-term drug effects, thereby informing regulatory decisions and clinical practice. The integration of pharmacovigilance and RWD is vital for ensuring drug safety and optimizing patient outcomes in the real world.